Tessari P, Inchiostro S, Zanetti M, Barazzoni R
Department of Metabolism, University of Padova, Italy.
Am J Physiol. 1995 Jul;269(1 Pt 1):E127-36. doi: 10.1152/ajpendo.1995.269.1.E127.
We propose a new six-compartment model of intracellular muscle kinetics of leucine and of its transamination product alpha-ketoisocaproic acid (KIC) by combining systemic tracer infusions of [14C]- and [15N]leucine with the arterial-deep venous catheterization of the human forearm. Venous [14C]KIC specific activity (SA) is taken as representative of intracellular [14C]leucine SA, whereas net [15N]leucine disposal is used to calculate leucine inflow and outflow across forearm cell membrane(s). In post-absorptive normal subjects, model-derived rates of intracellular leucine release from and incorporation into protein were approximately 32% (P = 0.03) and approximately 37% greater (P = 0.025), respectively, than those calculated using a conventional arteriovenous approach. Forearm fasting proteolysis exceeded protein synthesis (P < 0.025), whereas leucine oxidation was greater than zero (P < 0.01), suggesting a net negative leucine (i.e., protein) balance. Leucine inflow from blood to cell represented approximately 30% of arterial leucine delivery; therefore approximately 70% of arterial leucine bypassed intracellular metabolism. This model provides a comprehensive description of regional leucine and KIC kinetics and new estimates of protein degradation and synthesis across the human forearm.
我们提出了一种新的六室模型,用于描述亮氨酸及其转氨产物α-酮异己酸(KIC)在细胞内的肌肉动力学。该模型通过将[14C] - 和[15N]亮氨酸的全身示踪剂输注与人前臂的动脉 - 深静脉插管相结合。静脉血中[14C]KIC的比活性(SA)被视为细胞内[14C]亮氨酸SA的代表,而净[15N]亮氨酸处置则用于计算亮氨酸跨前臂细胞膜的流入和流出。在吸收后正常受试者中,模型推导的细胞内亮氨酸从蛋白质释放和掺入蛋白质的速率分别比使用传统动静脉方法计算的速率高约32%(P = 0.03)和约37%(P = 0.025)。前臂空腹蛋白水解超过蛋白质合成(P < 0.025),而亮氨酸氧化大于零(P < 0.01),表明亮氨酸(即蛋白质)净负平衡。从血液到细胞的亮氨酸流入约占动脉亮氨酸输送的30%;因此,约70%的动脉亮氨酸绕过细胞内代谢。该模型全面描述了局部亮氨酸和KIC动力学,并对整个人类前臂的蛋白质降解和合成进行了新的估计。